HIV infection in the elderly

References

• AbergJAGallantJEAndersonJ2004Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of AmericaClin Infect Dis396092915356773
   PubMed Web of Science ®Google Scholar
• AnastosKLuDShiO2007The association of bone mineral density with HIV infection and antiretroviral treatment in womenAntivir Ther1210495818018763
   PubMed Web of Science ®Google Scholar
• ArnstenJHFreemanRHowardAA2007Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infectionAIDS216172317314524
   PubMed Web of Science ®Google Scholar
• BabikerAGPetoTPorterK2001Age as a determinant of survival in HIV infectionJ Clin Epidemiol54S162111750205
   PubMed Web of Science ®Google Scholar
• BangsbergDRHechtFMCharleboisED2000Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent populationAIDS143576610770537
   PubMed Web of Science ®Google Scholar
• BiggarRJKirbyKAAtkinsonJ2004Cancer risk in elderly persons with HIV/AIDSJ Acquir Immune Defic Syndr36861815213571
   PubMed Web of Science ®Google Scholar
• BonfantiPGiannattasioCRicciE2007HIV and metabolic syndrome: a comparison with the general populationJ Acquir Immune Defic Syndr454263117514013
   PubMed Web of Science ®Google Scholar
• BowmanLCarlstedtBCHancockEF1996Adverse drug reaction (ADR) occurrence and evaluation in elderly inpatientsPharmacoepidemiol Drug Saf591815088272
   PubMedGoogle Scholar
• BransonBMHandsfieldHHLampeMA2006Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settingsMMWR Recomm Rep5511716988643
   PubMedGoogle Scholar
• BresslerRBahlJJ2003Principles of drug therapy for the elderly patientMayo Clin Proc7815647714661688
   PubMed Web of Science ®Google Scholar
• ButtAADascombKKDesalvoKB2001Human immunodeficiency virus infection in elderly patientsSouth Med J9439740011332905
   PubMed Web of Science ®Google Scholar
• ButtAAFultzSLKwohCK2004Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfectionHepatology40115915239093
   PubMed Web of Science ®Google Scholar
• CarrACooperDA2000Adverse effects of antiretroviral therapyLancet35614233011052597
   PubMed Web of Science ®Google Scholar
• CarrASamarasKThorisdottirA1999Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort studyLancet3532093910382692
   PubMed Web of Science ®Google Scholar
• [CDC] Centers for Disease Control and Prevention19921993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and AdultsMMWR41120
   Google Scholar
• [CDC] Centers for Disease Control and Prevention1998AIDS among persons aged greater than or equal to 50 years – United States, 1991–1996MMWR4721279461049
   PubMedGoogle Scholar
• [CDC] Centers for Disease Control and Prevention2002Guidelines for preventing opportunistic infections among HIV-infected persons – 2002: recommendations of the US Public Health Service and the Infectious Diseases Society of AmericaMMWR51152
   Google Scholar
• [CDC] Centers for Disease Control and Prevention2006HIV/AIDS Surveillance Report, 2005 [online] Accessed June 1, 2007 URL: http://www.cdc.gov/hiv/topics/surveillance/resources/reports/
   Google Scholar
• [CDC] Centers for Disease Control and Prevention20072006 National Health Interview Survey [online] Accessed June 30, 2007 URL: http://www.cdc.gov/nchs/nhis.htm
   Google Scholar
• CliffordGMPoleselJRickenbachM2005Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapyJ Natl Cancer Inst974253215770006
   PubMed Web of Science ®Google Scholar
• CooperDGatellJRockstrohJ2007Results of BENCHMRK-1, a phase III study evaluating the efficacy and safety of a novel HIV-1 integrase inhibitor, in patients with triple-class resistant virus [conference abstract]14th Conference on Retroviruses and Opportunistic InfectionsLos Angeles, CA, USA
   Google Scholar
• CrumNFFurtekKJOlsonPE2005A review of hypogonadism and erectile dysfunction among HIV-infected men during the pre- and post-HAART eras: diagnosis, pathogenesis, and managementAIDS Patient Care STDS196557116232050
   PubMed Web of Science ®Google Scholar
• Crum-CianfloneNFBavaroMHaleB2007Erectile dysfunction and hypogonadism among men with HIVAIDS Patient Care STDS2191917263654
   PubMed Web of Science ®Google Scholar
• Dal MasoLFranceschiSPoleselJ2003Risk of cancer in persons with AIDS in Italy, 1985–1998Br J Cancer899410012838307
   PubMed Web of Science ®Google Scholar
• Department of Health and Human Services: Panel on Antiretroviral Guidelines for Adults and Adolescents2008Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents [online] Accessed January 29, 2008 URL: http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf
   Google Scholar
• DolanSEHuangJSKillileaKM2004Reduced bone density in HIV-infected womenAIDS184758315090800
   PubMed Web of Science ®Google Scholar
• DolderCRPattersonTLJesteDV2004HIV, psychosis and aging: past, present and futureAIDS18S354215075496
   PubMed Web of Science ®Google Scholar
• DouekDCMcFarlandRDKeiserPH1998Changes in thymic function with age and during the treatment of HIV infectionNature39669059872319
   PubMed Web of Science ®Google Scholar
• DubeMPSteinJHAbergJA2003Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials GroupClin Infect Dis376132712942391
   PubMed Web of Science ®Google Scholar
• EffrosRB2004T cell replicative senescence: pleiotropic effects on human agingAnn NY Acad Sci1019123615247004
   PubMed Web of Science ®Google Scholar
• EggerMMayMCheneG2002Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studiesLancet3601192912126821
   PubMed Web of Science ®Google Scholar
• El-SadrWGettlerJ1995Unrecognized human immunodeficiency virus infection in the elderlyArch Intern Med15518467811128
   PubMed Web of Science ®Google Scholar
• EngelsEAGoedertJJ2005Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and futureJ Natl Cancer Inst97407915769998
   PubMed Web of Science ®Google Scholar
• EngelsEAPfeifferRMGoedertJJ2006Trends in cancer risk among people with AIDS in the United States 1980–2002AIDS2016455416868446
   PubMed Web of Science ®Google Scholar
• EngelsEA2001Human immunodeficiency virus infection, aging, and cancerJ Clin Epidemiol54S293411750207
   PubMed Web of Science ®Google Scholar
• EspinozaLHallHIHardnettF2007Characteristics of persons with heterosexually acquired HIV infection, United States 1999–2004Am J Public Health97144917138918
   PubMed Web of Science ®Google Scholar
• EvansWEMcLeodHL2003Pharmacogenomics – drug disposition, drug targets, and side effectsN Engl J Med3485384912571262
   PubMed Web of Science ®Google Scholar
• Federal Interagency on Aging-Related Statistics2006Older Americans update 2006: key indicators of well-beingFederal Interagency Forum on Aging-Related StatisticsWashington D.CUS Government Printing Office
   Google Scholar
• Friis-MollerNReissPSabinCA2007Class of antiretroviral drugs and the risk of myocardial infarctionN Engl J Med35617233517460226
   PubMed Web of Science ®Google Scholar
• Friis-MollerNWeberRReissP2003Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the D:A:D studyAIDS1711799312819520
   PubMed Web of Science ®Google Scholar
• GeboKAFleishmanJAMooreRD2005Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 statesJ Acquir Immune Defic Syndr406091616284539
   PubMed Web of Science ®Google Scholar
• GrabarSKousignianISobelA2004Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIVAIDS1820293815577624
   PubMed Web of Science ®Google Scholar
• GrabarSWeissLCostagliolaD2006HIV infection in older patients in the HAART eraJ Antimicrob Chemother574716284223
   PubMed Web of Science ®Google Scholar
• GrossRBilkerWBFriedmanHM2001Effect of adherence to newly initiated antiretroviral therapy on plasma viral loadAIDS1521091711684930
   PubMed Web of Science ®Google Scholar
• HallHIByersRHLingQ2007Racial/ethnic and age disparities in HIV prevalence and disease progression among men who have sex with men in the United StatesAm J Public Health971060617463370
   PubMed Web of Science ®Google Scholar
• HammerSMSaagMSSchechterM2006Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panelJAMA2968274316905788
   PubMed Web of Science ®Google Scholar
• HardingRKarusDEasterbrookP2005Does palliative care improve outcomes for patients with HIV/AIDS? A systematic review of the evidenceSex Transm Infect8151415681714
   PubMed Web of Science ®Google Scholar
• HermanESKlotmanPE2003HIV-associated nephropathy: epidemiology, pathogenesis, and treatmentSemin Nephrol23200812704580
   PubMed Web of Science ®Google Scholar
• HinkinCHCastellonSAAtkinsonJH2001Neuropsychiatric aspects of HIV infection among older adultsJ Clin Epidemiol54S445211750209
   PubMed Web of Science ®Google Scholar
• HinkinCHHardyDJMasonKI2004Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuseAIDS18S192515075494
   PubMed Web of Science ®Google Scholar
• HPA Communicable Disease Surveillance Center (HIV and STI Department) and the Scottish Centre for Infection and Environmental Health. 2007. Unpublished Quarterly Surveillance Tables No. 74, 07/1.
   Google Scholar
• HughesCM2004Medication non-adherence in the elderly: how big is the problem?Drugs Aging2179381115382959
   PubMed Web of Science ®Google Scholar
• IloejeUHYuanYL’ItalienG2005Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patientsHIV Med6374415670251
   PubMed Web of Science ®Google Scholar
• IsentressPI2007Isentress™ (raltegravir) tablets [prescribing information]Merck and Co., IncWhitehouse Station, NJ, USA
   Google Scholar
• IntelencePI2008Intelence™ (etravirine) tablets [prescribing information]Tibotec IncRaritan, NJ, USA
   Google Scholar
• JusticeACMcGinnisKAAtkinsonJH2004Psychiatric and neuro-cognitive disorders among HIV-positive and negative veterans in care: Veterans Aging Cohort Five-Site StudyAIDS18S495915075498
   PubMed Web of Science ®Google Scholar
• KalayjianRCLandayAPollardRB2003Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumesJ Infect Dis18719243312792869
   PubMed Web of Science ®Google Scholar
• KarlovskyMLebedBMydloJH2004Increasing incidence and importance of HIV/AIDS and gonorrhea among men aged >/= 50 years in the US in the era of erectile dysfunction therapyScand J Urol Nephrol382475215204381
   PubMed Web of Science ®Google Scholar
• KinironsMTO’MahonyMS2004Drug metabolism and ageingBr J Clin Pharmacol57540415089805
   PubMed Web of Science ®Google Scholar
• KiserJJGerberJGPredhommeJA2008Drug-drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteersJ Acquir Immune Defic Syndr47570818176327
   PubMed Web of Science ®Google Scholar
• KleinRSLoYSantoroNDobsAS2005Androgen levels in older men who have or who are at risk of acquiring HIV infectionClin Infect Dis41179480316288406
   PubMed Web of Science ®Google Scholar
• KnobelHGuelarAValldecilloG2001Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-upAIDS151591311505000
   PubMed Web of Science ®Google Scholar
• LalezariJGoodrichJDeJesusE2007Efficacy and safety of maraviroc plus optimized background therapy in viremic, ART-experienced patients infected with CCR5-tropic HIV-1: 24-week results of a phase 2b/3 study in the US and Canada [conference abstract]14th Conference on Retroviruses and Opportunistic InfectionsLos Angeles, CA, USA
   Google Scholar
• LekasHMScrimshawEWSiegelK2005Pathways to HIV testing among adults aged fifty and older with HIV/AIDSAIDS Care176748716036254
   PubMed Web of Science ®Google Scholar
• LucasGMEustaceJASozioS2004Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort studyAIDS18541615090808
   PubMed Web of Science ®Google Scholar
• MackKAOryMG2003AIDS and older Americans at the end of the Twentieth CenturyJ Acquir Immune Defic Syndr33S687512853855
   PubMed Web of Science ®Google Scholar
• MaggioloFRavasioLRipamontiD2005Similar adherence rates favor different virologic outcomes for patients treated with nonnucleoside analogues or protease inhibitorsClin Infect Dis401586315614706
   PubMed Web of Science ®Google Scholar
• ManfrediRChiodoF2000A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced ageAIDS141475710930176
   PubMed Web of Science ®Google Scholar
• ManfrediR2002HIV disease and advanced age: an increasing therapeutic challengeDrugs Aging196476912381235
   PubMed Web of Science ®Google Scholar
• MulliganKGrunfeldCTaiVW2000Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infectionJ Acquir Immune Defic Syndr23354310708054
   PubMed Web of Science ®Google Scholar
• National Centre in HIV Epidemiology, Clinical Research2007Australian HIV Surveillance Report231
   Google Scholar
• NaylorKLiGVallejoAN2005The influence of age on T cell generation and TCR diversityJ Immunol17474465215905594
   PubMed Web of Science ®Google Scholar
• NelsonMFatkenheuerGKonourinaI2007Efficacy and safety of maraviroc plus optimized background therapy in viremic, ART-experienced patients infected with CCR5-tropic HIV-1 in Europe, Australia, and North America: 24-week results [conference abstract]14th Conference on Retroviruses and Opportunistic InfectionsLos Angeles, CA, USA
   Google Scholar
• NoguerasMNavarroGAntonE2006Epidemiological and clinical features, response to HAART, and survival in HIV-infected patients diagnosed at the age of 50 or moreBMC Infect Dis615917087819
   PubMed Web of Science ®Google Scholar
• PalaciosRSantosJGarciaA2006Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patientsHIV Med710516313287
   PubMed Web of Science ®Google Scholar
• PalaciosRSantosJ2007Blood pressure and antiretroviral therapyAIDS2152917301577
   PubMed Web of Science ®Google Scholar
• PanGYangZBallingerSW2006Pathogenesis of osteopenia/osteoporosis induced by highly active antiretroviral therapy for AIDSAnn NY Acad Sci106829730816831930
   PubMed Web of Science ®Google Scholar
• ParedesRMocroftAKirkO2000Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA studyArch Intern Med16011233210789605
   PubMed Web of Science ®Google Scholar
• PatersonDLSwindellsSMohrJ2000Adherence to protease inhibitor therapy and outcomes in patients with HIV infectionAnn Intern Med133213010877736
   PubMed Web of Science ®Google Scholar
• Public Health Agency of Canada2006HIV and AIDS in CanadaSurveillance report to June 30, 2006Surveillance and Risk Assessment Division, Centre for Infectious Disease Prevention and Control, Health Canada
   Google Scholar
• RamsayLETuckerGT1981Clinical pharmacology: drugs and the elderlyBr Med J (Clin Res Ed)2821257
   Web of Science ®Google Scholar
• SandersGDSundaramVBayoumiAMin pressCost effectiveness of HIV screening in the elderlyAnn Intern Med
   Google Scholar
• SchambelanMBensonCACarrA2002Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panelJ Acquir Immune Defic Syndr312577512439201
   PubMed Web of Science ®Google Scholar
• SchlenkEADunbar-JacobJEngbergS2004Medication non-adherence among older adults: a review of strategies and interventions for improvementJ Gerontol Nurs30334315287325
   PubMedGoogle Scholar
• SchoenbaumEEHartelDLoY2005HIV infection, drug use, and onset of natural menopauseClin Infect Dis4115172416231267
   PubMed Web of Science ®Google Scholar
• SelzentryPI2007Selzentry™ (maraviroc) tablets [prescribing information]Pfizer IncNew York, NY, USA
   Google Scholar
• ShahSMildvanD2006HIV and AgingCurr Infect Dis Rep8241716643776
   PubMedGoogle Scholar
• ShahSSMcGowanJPSmithC2002Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York CityClin Infect Dis3512384312410484
   PubMed Web of Science ®Google Scholar
• SilverbergMLLeydenWHorbergMA2007Older age and the response to and tolerability of antiretroviral therapyArch Intern Med1676849117420427
   PubMed Web of Science ®Google Scholar
• SkapikJLTreismanGJ2007HIV, psychiatric comorbidity, and agingClinical Geriatrics152636
   Google Scholar
• SkiestDJRubinstienECarleyN1996The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control studyAm J Med101605119003107
   PubMed Web of Science ®Google Scholar
• SotaniemiEAArrantoAJPelkonenO1997Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditionsClin Pharmacol Ther6133199091249
   PubMed Web of Science ®Google Scholar
• StallRCataniaJ1994AIDS risk behaviors among late middle-aged and elderly Americans. The National AIDS Behavioral SurveysArch Intern Med15457638267490
   PubMed Web of Science ®Google Scholar
• SteigbigelRKumarPEronJ2007Results of BENCHMRK-2, a phase III study evaluating the efficacy and safety of a novel HIV-1 integrase inhibitor, in patients with triple-class resistant virus [conference abstract]14th Conference on Retroviruses and Opportunistic InfectionsLos Angeles, CA, USA
   Google Scholar
• TumbarelloMRabagliatiRDe Gaetano-DonatiK2004Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapyBMC Infect Dis44615530169
   PubMed Web of Science ®Google Scholar
• ValcourVShikumaCShiramizuB2004Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 CohortNeurology63822715365130
   PubMed Web of Science ®Google Scholar
• van der LeeMSankatsingRSchippersE2007Pharmacokinetics and pharmacodynamics of combined used of lopinavir/ritonavir and rosuvastatin in HIV-infected patientsAntivir Ther1211272318018771
   PubMed Web of Science ®Google Scholar
• WellonsMFSandersLEdwardsLJ2002HIV infection: treatment outcomes in older and younger adultsJ Am Geriatr Soc50603711982658
   PubMed Web of Science ®Google Scholar
• WutohAKElekwachiOClarke-TaskerV2003Assessment and predictors of antiretroviral adherence in older HIV-infected patientsJ Acquir Immune Defic Syndr33S1061412853859
   PubMed Web of Science ®Google Scholar
• YungRLMoR2003Aging is associated with increased human T cell CC chemokine receptor gene expressionJ Interferon Cytokine Res235758214585197
   PubMed Web of Science ®Google Scholar
• ZablotskyDKennedyM2003Risk factors and HIV transmission to midlife and older women: knowledge, options, and the initiation of safer sexual practicesJ Acquir Immune Defic Syndr33S1223012853861
   PubMed Web of Science ®Google Scholar